TCMD Jul 2024 7.500 call
| Previous close | 7.70 |
| Open | 7.70 |
| Bid | 7.10 |
| Ask | 9.90 |
| Strike | 7.50 |
| Expiry date | 2024-07-19 |
| Day's range | 7.70 - 7.70 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksTactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 54.55% and 3.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GuruFocus.comTactile Systems Technology Inc (TCMD) Q1 2024 Earnings: Narrower Operating Loss and Revenue Growth
Insights into Tactile Systems' Financial Performance and Strategic Focus
GlobeNewswireTactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results
Reaffirms Full Year 2024 OutlookMINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Summary: Total revenue increased 4% year-over-year to $61.1 million Lymphedema product revenue increased 5% year-over-yearAirway clearance product revenue dec
